Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer, improving outcomes in patients with advanced malignancies. The use of ICIs in clinical practice, and the number of ICI clinical trials, are rapidly increasing. The use of ICIs in combination with other forms of cancer t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Reynolds, Kerry L, Arora, Shaily, Elayavilli, Ravikumar Komandur, Louv, William C, Schaller, Teilo H, Khandelwal, Aakanksha, Rothenberg, Mace, Khozin, Sean, Guidon, Amanda C, Dougan, Michael, Zubiri, Leyre, Petrillo, Laura, Sise, Meghan E, Villani, Alexandra-Chloe, Johnson, Douglas B, Rahma, Osama, Sharon, Elad
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2021
Assuntos:
Position Article and Guidelines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8256840/
https://ncbi.nlm.nih.gov/pubmed/34215691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2021-002896
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados